GW Pharmaceuticals Plc ADR (GWPH)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | HEALTH CARE SUPPLIES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Justin D. Gover |
| Employees: | 496 |
| Web site: | www.gwpharm.com |
|
SOVEREIGN HOUSE, VISION PARK, HISTON, CAMBRIDGE CB24 9BZ, X0, 00000
44 1223 266800
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. The company operates through the following segments: Commercial, Sativex Research & Development, and Pipeline Research & Development. The Commercial segment distributes and sells the commercial products and promotes Sativex through collaborations with pharmaceutical companies for the currently approved indication of spasticity due to multiple sclerosis. The Sativex Research & Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research & Development segment seeks to develop cannabinoid medications other than Sativex, which are using the proprietary cannabinoid technology platform. The company was founded by Geoffrey W. Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
Please log in first to see chart